Literature DB >> 10722512

Pronounced postantibiotic effect of quinupristin-dalfopristin in static cultures of Staphylococcus aureus: an effect not seen with other antibiotics.

E Pfeil1, B Wiedemann.   

Abstract

Quinupristin-dalfopristin produced postantibiotic effects (PAEs) on exponentially growing (log phase) and nongrowing (lag phase) cultures of 0.4 to 6.9 h. PAEs of the other antibiotics tested were 0.5 to 1.9 h, determined with exponentially growing cultures. None of these antibiotics show a PAE on lag-phase bacteria.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10722512      PMCID: PMC89813          DOI: 10.1128/AAC.44.4.1059-1061.2000

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN: 0066-4804            Impact factor:   5.191


  7 in total

1.  Post-antibiotic effect of the new streptogramin RP 59500.

Authors:  N X Chin; H C Neu
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1992-07       Impact factor: 3.267

2.  Post-antibiotic effects of RP 59500 with Staphylococcus aureus.

Authors:  A Nougayrede; N Berthaud; D H Bouanchaud
Journal:  J Antimicrob Chemother       Date:  1992-07       Impact factor: 5.790

3.  Irreversible binding of pristinamycin IIA (streptogramin A) to ribosomes explains its "lasting damage" effect.

Authors:  M Aumercier; S Bouhallab; M L Capmau; F Le Goffic
Journal:  J Antibiot (Tokyo)       Date:  1986-09       Impact factor: 2.649

4.  Differences between bacteria grown in vitro and in vivo.

Authors:  A Dalhoff
Journal:  J Antimicrob Chemother       Date:  1985-01       Impact factor: 5.790

5.  Postantibiotic suppression of bacterial growth.

Authors:  R W Bundtzen; A U Gerber; D L Cohn; W A Craig
Journal:  Rev Infect Dis       Date:  1981 Jan-Feb

6.  Postantibiotic effect and postantibiotic sub-MIC effect of quinupristin-dalfopristin against gram-positive and -negative organisms.

Authors:  G A Pankuch; M R Jacobs; P C Appelbaum
Journal:  Antimicrob Agents Chemother       Date:  1998-11       Impact factor: 5.191

7.  RP 59500: a proposed mechanism for its bactericidal activity.

Authors:  M Aumercier; S Bouhallab; M L Capmau; F Le Goffic
Journal:  J Antimicrob Chemother       Date:  1992-07       Impact factor: 5.790

  7 in total
  1 in total

Review 1.  Moxifloxacin in uncomplicated skin and skin structure infections.

Authors:  Richard B R Muijsers; Blair Jarvis
Journal:  Drugs       Date:  2002       Impact factor: 9.546

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.